Edition:
India

Masimo Corp (MASI.OQ)

MASI.OQ on NASDAQ Stock Exchange Global Select Market

86.86USD
15 Dec 2017
Change (% chg)

$2.20 (+2.60%)
Prev Close
$84.66
Open
$84.75
Day's High
$87.09
Day's Low
$84.75
Volume
363,767
Avg. Vol
164,542
52-wk High
$104.71
52-wk Low
$64.76

Chart for

About

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $4,526.06
Shares Outstanding(Mil.): 51.94
Dividend: --
Yield (%): --

Financials

BRIEF-Masimo ‍announces FDA clearance and U.S. release Of full family of NomoLine capnography sampling lines​

* ‍ANNOUNCES FDA CLEARANCE AND U.S. RELEASE OF FULL FAMILY OF NOMOLINE CAPNOGRAPHY SAMPLING LINES​ Source text for Eikon: Further company coverage:

27 Nov 2017

BRIEF-‍San Diego bankruptcy court issues final judgment on Masimo Corp

* Masimo Corp - ‍Bankruptcy court in San Diego has issued final judgment, holding that "Sotera Wireless employees misappropriated Masimo trade secrets"​ Source text for Eikon: Further company coverage:

17 Oct 2017

BRIEF-Masimo reports FDA clearance and full market release of rad-97 pulse co-oximeter

* Masimo announces FDA clearance and full market release of rad-97™ pulse co-oximeter® Source text for Eikon: Further company coverage:

18 Sep 2017

BRIEF-Masimo says CFO Mark De Raad to retire ‍​

* Masimo Corp - On August 23, Mark P. De Raad, CFO, notified co of his intention to retire and resign from his roles with the company‍​ ‍​

25 Aug 2017

BRIEF-Dubai Health Authority implementiert Masimo Patient SafetyNet

* Dubai Health Authority implementiert Masimo Patient SafetyNet Source text for Eikon: Further company coverage:

15 Aug 2017

BRIEF-Masimo Q2 earnings per share $0.83

* Q2 earnings per share view $0.71 -- Thomson Reuters I/B/E/S

03 Aug 2017

Earnings vs. Estimates